Rivastigmine: A Pharmacoeconomic Review of its Use in Alzheimers Disease

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.3, 2001-03, pp. : 303-318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review of rivastigmine and its clinical applications in Alzheimer’s disease and related disorders

By Desai A. Grossberg G.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 653-666

Informa Healthcare

Access to resources Recommend Favorite

Rivastigmine: A Review of its Use in Alzheimer's Disease

By Spencer C.M. Noble S.

Drugs & Aging, Vol. 13, Iss. 5, 1998-11 ,pp. : 391-411

Adis International

Access to resources Recommend Favorite

Galantamine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease

By Lyseng-Williamson K.A. Plosker G.L.

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 919-942

Adis International

Access to resources Recommend Favorite

Metrifonate: A Review of its Use in Alzheimers Disease

By Ormrod D. Spencer C.

CNS Drugs, Vol. 13, Iss. 6, 2000-06 ,pp. : 443-467

Adis International

Access to resources Recommend Favorite

Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease

By Plosker Greg L. Lyseng-Williamson Katherine A.

PharmacoEconomics, Vol. 23, Iss. 2, 2005-01 ,pp. : 193-206

Adis International

Access to resources Recommend Favorite